skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Refinado por: Nome da Publicação: British Journal Of Dermatology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry

Gisondi, P. ; Bianchi, L. ; Calzavara‐Pinton, P. ; Conti, A. ; Chiricozzi, A. ; Fimiani, M. ; Pellegrino, M. ; Giunta, A. ; Prignano, F. ; Tiberio, R. ; Venturini, M. ; Girolomoni, G.

British journal of dermatology (1951), 2019-02, Vol.180 (2), p.409-410 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
12
Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)
Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)

Thaci, D. ; Piaserico, S. ; Warren, R.B. ; Gupta, A.K. ; Cantrell, W. ; Draelos, Z. ; Foley, P. ; Igarashi, A. ; Langley, R.G. ; Asahina, A. ; Young, M. ; Falqués, M. ; Pau‐Charles, I. ; Mendelsohn, A.M. ; Rozzo, S.J. ; Reich, K.

British journal of dermatology (1951), 2021-08, Vol.185 (2), p.323-334 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
13
Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks
Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks

Reich, K. ; Warren, R.B. ; Iversen, L. ; Puig, L. ; Pau‐Charles, I. ; Igarashi, A. ; Ohtsuki, M. ; Falqués, M. ; Harmut, M. ; Rozzo, S. ; Lebwohl, M.G. ; Cantrell, W. ; Blauvelt, A. ; Thaçi, D.

British journal of dermatology (1951), 2020-03, Vol.182 (3), p.605-617 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
14
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Papp, K. ; Gottlieb, A. ; Reich, K. ; Maari, C. ; Gordon, K.B. ; Lima, R.G. ; Elmaraghy, H. ; Gallo, G. ; Renda, L. ; Park, S.Y. ; Burge, R. ; Bagel, J. ; Vender, Ronald ; Hong, Chih‐Ho ; Langley, Richard L. ; Albrecht, Lorne ; Guenther, Lyn ; Papp, Kim ; Singh Ohson, Kamal K. ; Barber, Kirk ; Lynde, Charles ; Gupta, Aditya ; Rosoph, Leslie ; Gauthier, Jean‐Sébastien ; Gooderham, Melinda ; Wasel, Norman ; Wiseman, Marni ; Greenstein, David ; Jarell, Abel ; Moon, Charles ; Bukhalo, Michael ; Moore, Angela ; Hamilton, Tiffani K. ; Gewirtzman, Aron ; Hazan, Lydie ; Crowley, Jeffrey ; Teller, Craig ; Smith, Stacy R. ; Christine Lee, M. ; Lee, Patricia ; Dhawan, Sunil ; Leonardi, Craig ; Jesus, Amarilis Perez‐De ; McFalda, Wendy ; Fretzin, Scott ; Schlesinger, Todd ; Gottlieb, Scott ; Jenkin, Peter ; Gharib, Rola ; Davis, Steven ; Draelos, Zoe Diana ; Godwin, Lloyd ; Landis, Megan ; Sanchez‐Rivera, Samuel ; Fivenson, David ; Kerdel, Francisco ; Forman, Seth B. ; Gonzalez‐Chavez, Jose ; Boyce, Brent ; Stein‐Gold, Linda ; Hudson, Charles ; Brown, Constance ; Coggi, James ; Feser, Christina ; McCune, Mark ; Madkan, Vandana ; Shipp, Dana Maxwell ; Soto‐Raices, Oscar ; Cather, Jennifer ; Miller, Scott ; Scott, John ; Young, Douglas ; Yokum, Kelley ; McCracken, Gary ; McElgunn, Patrick ; Herrmann, James ; Appel, James ; Barranco, Elizabeth ; Cauthen, Ashley ; Sadick, Neil ; De La Torre, Eneida ; Taylor, Kelly ; Harris, Holly Hake ; Soung, Jennifer ; Dimitropoulos, Vassilios ; Miller, Stephen ; Barnes, Cathy ; Jumean‐Haddad, Rawan ; Guenthner, Scott ; Laquer, Vivian ; Jacobs, Shahram ; Nahm, Walter ; Korman, Neil ; Elewski, Boni ; Ferris, Laura ; Duffin, Kristina Callis ; Pariser, David ; Johnson, Brian ; Travers, Jeffrey ; Fried, Richard

British journal of dermatology (1951), 2020-06, Vol.182 (6), p.1348-1358 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
15
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry

Zweegers, J. ; van den Reek, J.M.P.A. ; van de Kerkhof, P.C.M. ; Otero, M.E. ; Kuijpers, A.L.A. ; Koetsier, M.I.A. ; Arnold, W.P. ; Berends, M.A.M. ; Weppner-Parren, L. ; Ossenkoppele, P.M. ; Njoo, M.D. ; Mommers, J.M. ; van Lümig, P.P.M. ; Driessen, R.J.B. ; Kievit, W. ; de Jong, E.M.G.J.

British journal of dermatology (1951), 2016-08, Vol.175 (2), p.340-347 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
16
Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: a pooled analysis from 10 clinical trials
Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: a pooled analysis from 10 clinical trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: a pooled analysis from 10 clinical trials

Nast, A. ; Dilleen, M. ; Liyanage, W. ; Aikman, L. ; Szczypa, P. ; Dressler, C.

British journal of dermatology (1951), 2018-02, Vol.178 (2), p.400-405 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
17
Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Iskandar, I.Y.K. ; Ashcroft, D.M. ; Warren, R.B. ; Evans, I. ; McElhone, K. ; Owen, C.M. ; Burden, A.D. ; Smith, C.H. ; Reynolds, N.J. ; Griffiths, C.E.M.

British journal of dermatology (1951), 2017-05, Vol.176 (5), p.1297-1307 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
18
Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis
Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis

Egeberg, A. ; Ottosen, M.B. ; Gniadecki, R. ; Broesby‐Olsen, S. ; Dam, T.N. ; Bryld, L.E. ; Rasmussen, M.K. ; Skov, L.

British journal of dermatology (1951), 2018-02, Vol.178 (2), p.509-519 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
19
Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3)
Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3)

Papp, K.A. ; Leonardi, C.L. ; Blauvelt, A. ; Reich, K. ; Korman, N.J. ; Ohtsuki, M. ; Paul, C. ; Ball, S. ; Cameron, G.S. ; Erickson, J. ; Zhang, L. ; Mallbris, L. ; Griffiths, C.E.M.

British journal of dermatology (1951), 2018-03, Vol.178 (3), p.e242-e242 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
20
A study of the drug tildrakizumab for plaque psoriasis
A study of the drug tildrakizumab for plaque psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

A study of the drug tildrakizumab for plaque psoriasis

Kimball, A.B. ; Papp, K.A. ; Reich, K. ; Gooderham, M. ; Li, Q. ; Cichanowitz, N. ; La Rosa, C. ; Blauvelt, A.

British journal of dermatology (1951), 2020-06, Vol.182 (6), p.e196-e196 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.